158 related articles for article (PubMed ID: 24095676)
21. Targeting HIF function: the debate continues.
Vyas P
Blood; 2014 Dec; 124(24):3510-1. PubMed ID: 25477482
[No Abstract] [Full Text] [Related]
22. CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?
Tettamanti S; Biondi A; Biagi E; Bonnet D
Oncoimmunology; 2014; 3():e28835. PubMed ID: 25083319
[TBL] [Abstract][Full Text] [Related]
23. Leukemia propagating cells rebuild an evolving niche in response to therapy.
Duan CW; Shi J; Chen J; Wang B; Yu YH; Qin X; Zhou XC; Cai YJ; Li ZQ; Zhang F; Yin MZ; Tao Y; Mi JQ; Li LH; Enver T; Chen GQ; Hong DL
Cancer Cell; 2014 Jun; 25(6):778-93. PubMed ID: 24937459
[TBL] [Abstract][Full Text] [Related]
24. Metabolic requirements for the maintenance of self-renewing stem cells.
Ito K; Suda T
Nat Rev Mol Cell Biol; 2014 Apr; 15(4):243-56. PubMed ID: 24651542
[TBL] [Abstract][Full Text] [Related]
25. Concise review: genetic dissection of hypoxia signaling pathways in normal and leukemic stem cells.
Gezer D; Vukovic M; Soga T; Pollard PJ; Kranc KR
Stem Cells; 2014 Jun; 32(6):1390-7. PubMed ID: 24496882
[TBL] [Abstract][Full Text] [Related]
26. Forgotten gems: human CD34(-) hematopoietic stem cells.
Anjos-Afonso F; Bonnet D
Cell Cycle; 2014; 13(4):503-4. PubMed ID: 24419157
[No Abstract] [Full Text] [Related]
27. Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact.
Rouault-Pierre K; Hamilton A; Bonnet D
Expert Opin Biol Ther; 2016; 16(4):463-76. PubMed ID: 26679619
[TBL] [Abstract][Full Text] [Related]
28. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
Bonnet D; Dick JE
Nat Med; 1997 Jul; 3(7):730-7. PubMed ID: 9212098
[TBL] [Abstract][Full Text] [Related]
29. The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.
Lawson H; Holt-Martyn JP; Dembitz V; Kabayama Y; Wang LM; Bellani A; Atwal S; Saffoon N; Durko J; van de Lagemaat LN; De Pace AL; Tumber A; Corner T; Salah E; Arndt C; Brewitz L; Bowen M; Dubusse L; George D; Allen L; Guitart AV; Fung TK; So CWE; Schwaller J; Gallipoli P; O'Carroll D; Schofield CJ; Kranc KR
Nat Cancer; 2024 Jun; 5(6):916-937. PubMed ID: 38637657
[TBL] [Abstract][Full Text] [Related]
30. Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells.
Velasco-Hernandez T; Trincado JL; Vinyoles M; Closa A; Martínez-Moreno A; Gutiérrez-Agüera F; Molina O; Rodríguez-Cortez VC; Ximeno-Parpal P; Fernández-Fuentes N; Petazzi P; Beneyto-Calabuig S; Velten L; Romecin P; Casquero R; Abollo-Jiménez F; de la Guardia RD; Lorden P; Bataller A; Lapillonne H; Stam RW; Vives S; Torrebadell M; Fuster JL; Bueno C; Sarry JE; Eyras E; Heyn H; Menéndez P
Hemasphere; 2024 Feb; 8(2):e45. PubMed ID: 38435427
[TBL] [Abstract][Full Text] [Related]
31. Contributions of transcriptional noise to leukaemia evolution: KAT2A as a case-study.
Pina C
Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1900):20230052. PubMed ID: 38432321
[TBL] [Abstract][Full Text] [Related]
32. HIF2-α Expression in CML Patients Receiving Hydroxyurea Prior to Imatinib That Achieved Major Molecular Response (MMR) versus in Those Not Achieving MMR.
Rinaldi I; Mauludi R; Jusman SW; Sinto R; Harimurti K
J Blood Med; 2024; 15():61-67. PubMed ID: 38375065
[TBL] [Abstract][Full Text] [Related]
33. Leukemia and mitophagy: a novel perspective for understanding oncogenesis and resistance.
Liu Y; Ma Z
Ann Hematol; 2024 Jan; ():. PubMed ID: 38282059
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies.
Zhang H; Sun C; Sun Q; Li Y; Zhou C; Sun C
Front Mol Biosci; 2023; 10():1275774. PubMed ID: 37818101
[TBL] [Abstract][Full Text] [Related]
35. The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia.
Magliulo D; Simoni M; Caserta C; Fracassi C; Belluschi S; Giannetti K; Pini R; Zapparoli E; Beretta S; Uggè M; Draghi E; Rossari F; Coltella N; Tresoldi C; Morelli MJ; Di Micco R; Gentner B; Vago L; Bernardi R
EMBO Mol Med; 2023 Nov; 15(11):e17810. PubMed ID: 37807875
[TBL] [Abstract][Full Text] [Related]
36. Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia.
Humphries S; Bond DR; Germon ZP; Keely S; Enjeti AK; Dun MD; Lee HJ
Clin Epigenetics; 2023 Sep; 15(1):150. PubMed ID: 37705055
[TBL] [Abstract][Full Text] [Related]
37. NADPH oxidase mediated oxidative stress signaling in FLT3-ITD acute myeloid leukemia.
Chen Y; Zou Z; Găman MA; Xu L; Li J
Cell Death Discov; 2023 Jun; 9(1):208. PubMed ID: 37391442
[TBL] [Abstract][Full Text] [Related]
38. Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells.
Qiu S; Sheth V; Yan C; Liu J; Chacko BK; Li H; Crossman DK; Fortmann SD; Aryal S; Rennhack A; Grant MB; Welner RS; Paterson AJ; Wende AR; Darley-Usmar VM; Lu R; Locasale JW; Bhatia R
Blood; 2023 Aug; 142(6):574-588. PubMed ID: 37192295
[TBL] [Abstract][Full Text] [Related]
39. mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells.
Panuzzo C; Pironi L; Maglione A; Rocco S; Stanga S; Riganti C; Kopecka J; Ali MS; Pergolizzi B; Bracco E; Cilloni D
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674750
[TBL] [Abstract][Full Text] [Related]
40. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes.
Berastegui N; Ainciburu M; Romero JP; Garcia-Olloqui P; Alfonso-Pierola A; Philippe C; Vilas-Zornoza A; San Martin-Uriz P; Ruiz-Hernández R; Abarrategi A; Ordoñez R; Alignani D; Sarvide S; Castro-Labrador L; Lamo-Espinosa JM; San-Julian M; Jimenez T; López-Cadenas F; Muntion S; Sanchez-Guijo F; Molero A; Montoro MJ; Tazón B; Serrano G; Diaz-Mazkiaran A; Hernaez M; Huerga S; Bewicke-Copley F; Rio-Machin A; Maurano MT; Díez-Campelo M; Valcarcel D; Rouault-Pierre K; Lara-Astiaso D; Ezponda T; Prosper F
Nat Commun; 2022 Dec; 13(1):7619. PubMed ID: 36494342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
